Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Telix and ANMI to commercialize prostate cancer imaging agent; create JV in the US

Executive Summary

Telix Pharmaceuticals Ltd. and Advanced Nuclear Medicine Ingredients SA (ANMI) partnered to commercialize a prostate cancer imaging technology in the US.
Deal Industry
  • Pharmaceuticals
    • Radiopharmaceuticals, Contrast Agents
Deal Status
  • Final
Deal Type
  • Alliance
    • Joint Venture
    • Marketing-Licensing

Related Companies